Peak Research

1. Taro Pharmaceuticals USA, Inc. $359,360 65 payments
2. Aclaris Therapeutics, Inc. $256,175 19 payments
3. Sun Pharmaceutical Industries Inc. $133,055 28 payments
4. Teva Pharmaceuticals USA, Inc. $40,590 4 payments

1. A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice A Week in Subjects With Common Warts $256,175 19 payments
2. Ivrc 2002 $164,520 17 payments
3. Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata $82,418 12 payments
4. RXLC 2118 $67,000 17 payments
5. Study $46,565 11 payments
6. BTCG 1808 $44,386 10 payments
7. A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Design Group Study to Evaluate the Therapeutic Equivalence Comparing Trifarotene Cream, 0.005% (Teva Pharmaceuticals, Inc. to Aklief (Trifarotene 0.005% Cream) (Galderma Laboratories, L.P., USA), in the Treatment of Acne Vulgaris $40,590 4 payments
8. To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15 Topical Gel $26,040 8 payments
9. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $14,768 4 payments
10. HLBT 2001 $14,165 5 payments

1. Professional salary support $250,890 39 payments
2. Overhead $18,250 4 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.